Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 360 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Christian A. G.

Germany

USD 360 /hr

Cardiology Advisor for Pharma & MedTech | Medical Strategy, Real-World Insights & Implementation

Profile Summary

Executive Summary Cardiologist, chief physician and academically trained clinical scientist with proven experience in patient care, research, leadership and medical-strategic advisory work. For pharma and MedTech companies, this profile combines a key opinion leader perspective, real-world healthcare insight, advisory board experience and hands-on implementation expertise across inpatient and outpatient cardiology care settings. Advisor Profile for Pharma and MedTech Clients The advisory focus is on translating medical evidence into compelling product positioning, Medical Affairs strategies, educational formats and practical implementation concepts. Clients benefit from the ability to assess clinical need, target-group acceptance, healthcare delivery barriers and differentiation potential from the combined perspective of hospital leadership, outpatient car-diology, academic research and daily physician practice. - Medical & Scientific Strategy: Evaluation of evidence, guideline alignment, patient benefit, real-world applicability, study and healthcare relevance, and the medical plausibility of prod-uct and service concepts - Market Access, Adoption & Stakeholder Fit: Assessment of market barriers, HCP ac-ceptance, referral pathways, training needs, clinical decision-making processes and prereq-uisites for sustainable implementation in routine care - Proven Application: Set-up of interventional cardiology services and an outpatient cardiolo-gy center, leadership of specialized outpatient clinics, national pharma advisory boards in lip-idology and atherosclerosis, healthcare startup advisory, educational programs and public outreach Professional Experience with Advisory Relevance Rottal-Inn Kliniken, Eggenfelden, Germany Chief Physician, Cardiology and Stroke Center (since 09/2018) - Overall responsibility for the cardiology department and stroke center, covering inpatient and outpatient care in a regional general-care hospital - Set-up and strategic development of interventional cardiology, including service portfolio, process architecture, patient referral pathways and quality management - Leadership, recruitment and development of interprofessional teams; responsibility for quali-ty, efficiency, medical training, process optimization and external positioning - Approximately 3,500 inpatients and more than 1,200 cardiac catheterization procedures and interventions per year Set-up and Medical Director, Outpatient Cardiology Center Rottal-Inn, Eggenfelden / Pfarrkirchen (2019–2025) - Concept and set-up of an outpatient cardiology unit to strengthen regional care and comple-ment the inpatient service portfolio - Integration of outpatient and inpatient services, standardized treatment and organizational processes, referral network development and interface management Heidelberg University Hospital, Department of Internal Medicine III / Cardiology, Angiology and Pulmonology Senior Consultant Cardiologist / Deputy Head of Department (2011–2018) - Senior clinical role at a university center with broad responsibility in invasive and non-invasive cardiology - Leadership of specialized outpatient clinics, strategic clinical organization, training and super-vision of medical teams - Scientific working group leadership with international collaborations, third-party funding re-sponsibility, publication track record and translational research focus

Subject Matter Expertise

• ☆ Statistics
• ☆ Health Data Analysis
• ☆ Public Health
• ☆ Global Health
• ☆ Health Technology Assessment
• ☆ E-Health & Telemedicine
• ☆ Healthcare Administration & Management
• ☆ Managed Healthcare
• ☆ Healthcare Quality Improvement
• ☆ Health Risk Assessments
• ☆ Health Education
• ☆ Medical Writing
• ☆ Healthcare Communications
• ☆ Proofreading & Editing

Services

• Research
• Consulting

Research Feasibility Study, Fact Checking, Scientific and Technical Research, Systematic Literature Review

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Healthcare Consulting, Scientific and Technical Consulting

Work Experience

Head of Cardiology

Rottal-Inn Kliniken

September 2018 - Present

Head

Rottal-Inn Kliniken Eggenfelden

September 2018 - Present

Professor

Ruprecht Karls Universität Heidelberg: Heidelberg, Baden-Württemberg, DE

May 2017 - Present

Head of Cardiology

MVZ Rottal-Inn

April 2019 - January 2025

Deputy Head of Cardiology

GRN-Klinik Eberbach

September 2016 - August 2018

Attending Physician

Heidelberg University Hospital

July 2012 - August 2018

Physician

University Hospital Heidelberg

August 2002 - July 2018

Postdoctoral Fellow

La Jolla Institute for Immunology

November 2007 - October 2009

Postdoctoral Fellow

University of Virginia

June 2006 - October 2007

Education

Dr. med.

Heidelberg University - Study of Medicine

September 1995 - August 2002

(Neurology)

University College London

2002 - 2002

Dr. med. (Medicine)

Ruprecht Karls Universität Heidelberg

1995 - 2002

(Surgery)

Harvard Medical School

2001 - 2001

(Surgery)

University of Toronto

2001 - 2001

Certifications

• Lipidology

  German Society of Lipidology

  February 2024 - Present

• Cardiovasculare Intensive Care and Emergency Medicine

  German Cardiac Society

  December 2021 - Present

• Heart Failure

  German Cardiac Society

  October 2018 - Present

• Professorship

  University of Heidelberg

  June 2017 - Present

• Board Certificate Intensive Care

  Ärztekammer Nordbaden

  January 2017 - Present

• Hypertensiology

  German Hypertension Society

  March 2016 - Present

• Inverventional Cardiology

  German Cardiad Society

  June 2015 - Present

• Board Certificate Internal Medicine and Cardiology

  Ärztekammer Nordbaden

  October 2011 - Present

Publications

JOURNAL ARTICLE

Christian A. Gleissner, Jona B. Krohn, Laurine Kristin Sprehe, Florian Sicklinger, Julie Kawohl, Chiara Hess, Anja Spieler, Susanne Dihlmann, Larissa Eis, Hugo A. Katus, et al. (2025). CXCL4-Induced PBMCs Modulate Vascular Extracellular Matrix via Wnt5a-Dependent Matrix Metalloproteinase-7 and Calcifying Extracellular Vesicle Release . Arteriosclerosis, Thrombosis, and Vascular Biology.

Christian Albert Gleissner (2024). Kardiale Risikofaktoren im Blick: Kardiologische Abklärung bei Patienten mit retinalem Gefäßverschluss. Z. prakt. Augenheilkd.

Christian A. Gleissner, Jona B. Krohn, Clemens Neubauer, Simon Fischer, Christian Oberkanins, Hugo A. Katus (2023). Optimisation of individual cardiovascular risk assessment in a German coronary artery disease cohort using a commercial test for genetic polymorphisms – a pilot study . Acta Cardiologica.

Christian A. Gleissner, Jona B. Krohn, Clemens Neubauer, Simon Fischer, Christian Oberkanins, Hugo A. Katus (2023). Optimisation of individual cardiovascular risk assessment in a German coronary artery disease cohort using a commercial test for genetic polymorphisms – a pilot study . Acta Cardiologica.

Christian A. Gleissner, Jona B. Krohn, Y Nhi Nguyen, Mohammadreza Akhavanpoor, Christian Erbel, Gabriele Domschke, Fabian Linden, Marcus E. Kleber, Graciela Delgado, Winfried März, et al. (2022). Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies . Frontiers in Cardiovascular Medicine.

Manuela Sauter, Reinhard J. Sauter, Henry Nording, Chaolan Lin, Marcus Olbrich, Stella Autenrieth, Christian Gleissner, Martin Thunemann, Nadia Otero, Esther Lutgens, et al. (2022). Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis . iScience.

Christian Albert Gleissner (2022). Der transradiale Zugang im kardiogenen Schock. CardioNews.

Cheryl S Sultan, Michael Weitnauer, Martin Turinsky, Thorsten Kessler, Maik Brune, Christian A Gleissner, Florian Leuschner, Andreas H Wagner, Markus Hecker (2020). Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease . Cardiovascular Research.

Christian A. Gleissner, Gabriele Domschke (2019). CXCL4-induced macrophages in human atherosclerosis . Cytokine.

Christian A. Gleissner, Ivelina Urban, Martin Turinsky, Sviatlana Gehrmann, Jakob Morgenstern, Maik Brune, Moritz R. Milewski, Andreas H. Wagner, Cordula Rumig, Thomas Fleming, et al. (2019). 15-Deoxy-Δ12,14-Prostaglandin J ₂ Reinforces the Anti-Inflammatory Capacity of Endothelial Cells With a Genetically Determined NO Deficit . Circulation Research.

Christian Albert Gleissner (2019). Koronare Herzerkrankung – doch eine Entzündung?. Kompendium Herz-Kreislauf, Thieme-Verlag, ISSN 1860-4730.

Jennifer Nicolai, Nicole Müller, Stefan Noest, Stefanie Wilke, Jobst-Hendrik Schultz, Christian A Gleißner, Wolfgang Eich, Christiane Bieber (2018). To change or not to change – That is the question: A qualitative study of lifestyle changes following acute myocardial infarction . Chronic Illness.

Christian A. Gleissner, Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Felix Lasitschka, Andreas O. Doesch, Hugo A. Katus, Christian Erbel (2018). Adventitial tertiary lymphoid organ classification in human atherosclerosis . Cardiovascular Pathology.

Christian A. Gleissner, Haitham Abu Sharar, Bruna Gomes, Emmanuel Chorianopoulos, Ziya Kaya, Hugo A. Katus, Raffi Bekeredijan (2018). Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry . Advances in Interventional Cardiology.

Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Christian M. Helmes, Andreas O. Doesch, Marcus E. Kleber, Hugo A. Katus, Winfried Maerz (2017). Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study . Atherosclerosis.

Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Christian M. Helmes, Andreas O. Doesch, Marcus E. Kleber, Hugo A. Katus, Winfried Maerz (2017). Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study . Atherosclerosis.

Christian A. Gleissner, Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Susanne Wangler, Andreas O. Doesch, Hugo A. Katus, Christian Erbel (2017). The Two Faces of Interleukin-17A in Atherosclerosis . Current Drug Targets.

Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Christian Erbel, Christian A Gleissner, Fabrice F Darche, Dierk Thomas, Tom Bruckner, Hugo A Katus, Andreas O Doesch (2017). The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation . Therapeutics and Clinical Risk Management.

Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Christian Erbel, Christian A Gleissner, Fabrice F Darche, Dierk Thomas, Tom Bruckner, Hugo A Katus, Andreas O Doesch (2017). The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation . Therapeutics and Clinical Risk Management.

(2016). Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus . Histology and Histopathology.

Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Andreas O. Doesch, Sebastian J. Buss, Evangelos Giannitsis, Hugo A. Katus, Grigorios Korosoglou (2016). Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology . Atherosclerosis.

Christian A. Gleissner, Christian Erbel, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Andreas O. Doesch, Sebastian J. Buss, Evangelos Giannitsis, Hugo A. Katus, Grigorios Korosoglou (2016). Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology . Atherosclerosis.

Christian A. Gleissner (2016). Translational atherosclerosis research: From experimental models to coronary artery disease in humans . Atherosclerosis.

Christian Erbel, Gregor Rupp, Gabriele Domschke, Fabian Linden, Mohammadreza Akhavanpoor, Andreas O Doesch, Hugo A Katus, Christian A Gleissner (2016). Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia . Innate Immunity.

Christian A. Gleissner, Christian Erbel, Nodira Mukhammadaminova, Nael F. Osman, Nina P. Hofmann, Christian Steuer, Mohammadreza Akhavanpoor, Susanne Wangler, Sultan Celik, Andreas O. Doesch, et al. (2016). Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy . JACC: Cardiovascular Imaging.

Christian A. Gleissner, Christian Erbel, Grigorios Korosoglou, Pearlyn Ler, Mohammadreza Akhavanpoor, Gabriele Domschke, Fabian Linden, Andreas O. Doesch, Sebastian J. Buss, Evangelos Giannitsis, et al. (2015). CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology . PLOS ONE.

Christian A. Gleissner, Christian Erbel, Antonia Wolf, Felix Lasitschka, Fabian Linden, Gabriele Domschke, Mohammadreza Akhavanpoor, Andreas O. Doesch, Hugo A. Katus (2015). Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability . International Journal of Cardiology.

Christian Erbel, Mirjam Tyka, Christian M Helmes, Mohmmadreza Akhavanpoor, Gregor Rupp, Gabriele Domschke, Fabian Linden, Antonia Wolf, Andreas Doesch, Felix Lasitschka, et al. (2015). CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+ S100A8+ in vitro and in vivo . Innate Immunity.

Christian Erbel, Mirjam Tyka, Christian M Helmes, Mohmmadreza Akhavanpoor, Gregor Rupp, Gabriele Domschke, Fabian Linden, Antonia Wolf, Andreas Doesch, Felix Lasitschka, et al. (2015). CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7 ⁺ S100A8 ⁺ <i>in vitro</i> and <i>in vivo</i> . Innate Immunity.

Andreas Doesch, Matthias Helmschrott, Rasmus Rivinius, Arjang Ruhparwar, Bastian Schmack, Christian Erbel, Christian A Gleissner, Mohammadreza Akhavanpoor, Lutz Frankenstein, Philipp Ehlermann, et al. (2015). Advantageous effects of immunosuppression with&amp;nbsp;tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart&amp;nbsp;transplantation . Drug Design, Development and Therapy.

Christian A. Gleissner, Christian Erbel, Julia Haeussler, Mohammadreza Akhavanpoor, Gabriele Domschke, Fabian Linden, Andreas O. Doesch, G&#246;ran Conradson, Sebastian J. Buss, Nina P. Hofmann, et al. (2015). Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease . Clinical Research in Cardiology.

R. Rivinius, M. Helmschrott, V. Koch, F. Sedaghat-Hamedani, P. Fortner, F. F. Darche, D. Thomas, A. Ruhparwar, B. Schmack, M. Karck, et al. (2015). Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient . Case Reports in Transplantation.

C. A. Glei&#223;ner (2015). The vulnerable vessel . Hämostaseologie.

Andreas Doesch, Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Bastian Schmack, Berthold Klein, Christian Erbel, Christian A Gleissner, Mohammadreza Akhavanpoor, Lutz Frankenstein, et al. (2014). Analysis of malignancies in patients&amp;nbsp;after&amp;nbsp;heart transplantation with subsequent immunosuppressive therapy . Drug Design, Development and Therapy.

Christian A. Gleissner, Fabian Linden, Gabriele Domschke, Christian Erbel, Mohammadreza Akhavanpoor, Hugo A. Katus (2014). Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application . Frontiers in Physiology.

Mohammadreza Akhavanpoor, Christian A Gleissner, Stephanie Gorbatsch, Andreas Doesch, Hamidreza Akhavanpoor, Susanne Wangler, Frederik Jahn, Felix Lasitschka, Hugo Katus, Christian Erbel (2014). CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions . Drug Design, Development and Therapy.

Andreas Doesch, Matthias Helmschrott, Jan Beckendorf, Ceylan Akyol, Arjang Ruhparwar, Bastian Schmack, Christian Erbel, Christian Gleissner, Mohammadreza Akhavanpoor, Philipp Ehlermann, et al. (2014). Superior rejection profile during the first 24&amp;nbsp;months after heart transplantation under tacrolimus as baseline immunosuppressive regimen . Drug Design, Development and Therapy.

Christian A. Gleissner, Mohammadreza Akhavanpoor, Susanne Wangler, Grigorios Korosoglou, Hugo A. Katus, Christian Erbel (2014). Adventitial inflammation and its interaction with intimal atherosclerotic lesions . Frontiers in Physiology.

Christian A. Gleissner, Catherine Cornu, Christophe Dufays, S&#233;gol&#232;ne Gaillard, Fran&#231;ois Gueyffier, Michel Redonnet, Laurent Sebbag, Ana Roussouli&#232;res, Jan Groetzner, Hans B. Lehmkuhl, et al. (2014). Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta‐analysis . British Journal of Clinical Pharmacology.

Grzegorz Terszowski, Christian Klein, Martin Stern (2014). KIR/HLA Interactions Negatively Affect Rituximab- but Not GA101 (Obinutuzumab)-Induced Antibody-Dependent Cellular Cytotoxicity . The Journal of Immunology.

Christian A. Gleissner, Christian Erbel, Deniz Okuyucu, Mohammadreza Akhavanpoor, Li Zhao, Susanne Wangler, Maani Hakimi, Andreas Doesch, Thomas J. Dengler, Hugo A. Katus (2014). A human ex vivo atherosclerotic plaque model to study lesion biology . Journal of Visualized Experiments.

Andreas Doesch, Li Zhao, Christian Gleissner, Mohammadreza Akhavanpoor, David Rohde, Deniz Okuyucu, Maani Hakimi, Hugo A. Katus, Christian Erbel, Thomas Dengler (2014). Inhibition of B7-1 (CD80) by RhuDex&amp;reg; reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions . Drug Design, Development and Therapy.

Iftach Shaked, David B. Hanna, Christian Glei&#223;ner, Brenda Marsh, Jill Plants, Daniel Tracy, Kathryn Anastos, Mardge Cohen, Elizabeth T. Golub, Roksana Karim, et al. (2014). Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection . Arteriosclerosis, Thrombosis, and Vascular Biology.

Andreas Doesch, Maximilian Kraeuter, Matthias Helmschrott, Christian Erbel, Christian Gleissner, Lutz Frankenstein, Bastian Schmack, Arjang Ruhparwar, Philipp Ehlermann, Hugo A. Katus (2013). Conversion to generic cyclosporine A in stable chronic patients after heart transplantation . Drug Design, Development and Therapy.

Andreas Doesch, Susanne Mueller, Christian Gleissner, Lutz Frankenstein, Stefan Hardt, Arjang Ruhparwar, Philipp Ehlermann, Thomas Dengler, Hugo A. Katus, Christian Erbel (2013). Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study . Drug Design, Development and Therapy.

Christian A. Gleissner, Christian Erbel, Gregor Rupp, Christian M. Helmes, Mirjam Tyka, Fabian Linden, Andreas O. Doesch, Hugo A. Katus (2013). An in vitro model to study heterogeneity of human macrophage differentiation and polarization . Journal of Visualized Experiments.

Christian A. Gleissner, Christian Erbel, Gregor Rupp, Christian M. Helmes, Mirjam Tyka, Fabian Linden, Andreas O. Doesch, Hugo A. Katus (2013). An in vitro model to study heterogeneity of human macrophage differentiation and polarization . Journal of Visualized Experiments.

Gleissner, Andreas Doesch, I Gueler, Susanne Mueller, Matthias Helmschrott, C Oeing, Frankenstein, Ruhparwar, Ehlermann, Dengler, et al. (2013). Effects of vildagliptin (Galvus&amp;reg;) therapy in patients with type 2 diabetes mellitus after heart transplantation . Drug Design, Development and Therapy.

Christian A. Gleissner, Christian Erbel, Rukiye Taskin, Andreas Doesch, Thomas J Dengler, Susanne Wangler, Mohammadreza Akhavanpoor, Arjang Ruhparwar, Evangelos Giannitsis, Hugo A. Katus (2013). High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival . Transplant International.

Gleissner, Andreas Doesch, Repp, Hofmann, Erbel, Frankenstein, Constanze Schmidt, Ruhparwar, Zugck, Schnitzler, et al. (2012). Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients . Drug Design, Development and Therapy.

Christian A. Gleissner (2012). Platelet-Derived Chemokines in Atherogenesis: What’s New? . Current Vascular Pharmacology.

Christian A. Gleissner, Grigorios Korosoglou, Evangelos Giannitsis, Hugo A. Katus (2012). Subclinical Atherosclerosis and Chronic Troponin Elevation: The Voice of Silence in Diabetics . Journal of the American College of Cardiology.

Christian A. Gleissner (2012). Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis . Frontiers in Physiology.

Christian A. Gleissner, Christian Erbel, Thomas J. Dengler, Susanne Wangler, Felix Lasitschka, Florian Bea, Nadine Wambsganss, Maani Hakimi, Dittmar B&#246;ckler, Hugo A. Katus (2011). Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability . Basic Research in Cardiology.

C Erbel, J Achenbach, M Akhavanpoor, TJ Dengler, F Lasitschka, CA Gleissner, F Bea, HA Katus, G Szabo (2011). PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels . European Journal of Medical Research.

Christian A. Gleissner, Christian Schulz, Nina V. Leuschen, Thomas Fr&#246;hlich, Michael Lorenz, Susanne Pfeiler, Elisabeth Kremmer, Mirjam Kessler, Alexander G. Khandoga, Bernd Engelmann, et al. (2010). Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation . Blood.

Christian A Gleissner, Iftach Shaked, Kristina M Little, Klaus Ley (2010). CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages . The Journal of Immunology.

Christian A. Gleissner, Iftach Shaked, Christian Erbel, Dittmar Böckler, Hugo A. Katus, Klaus Ley (2010). CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages . Circulation Research.

Markus Sperandio, Klaus Ley, Christian A. Gleissner (2009). Glycosylation in immune cell trafficking . Immunological Reviews.

Christian A. Gleissner, Thomas J. Dengler (2009). Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications . Human Immunology.

Christian A. Gleissner, Philipp von Hundelshausen, Klaus Ley (2008). Platelet Chemokines in Vascular Disease . Arteriosclerosis, Thrombosis, and Vascular Biology.

Mathias H Konstandin, Erwin Blessing, Andreas Doesch, Kerstin Ammon, Achim Koch, Guido H Wabnitz, Christian A Gleissner, Andrew Remppis, Hugo A Katus, Thomas J Dengler (2008). Ezetimibe effectively lowers LDL‐cholesterol in cardiac allograft recipients on stable statin therapy . Clinical Transplantation.

Christian A. Gleissner, John M. Sanders, Jerry Nadler, Klaus Ley (2008). Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis . Arteriosclerosis, Thrombosis, and Vascular Biology.

Christian A. Gleissner, Elena Galkina, Jerry L. Nadler, Klaus Ley (2007). Mechanisms by which diabetes increases cardiovascular disease . Drug Discovery Today: Disease Mechanisms.

Christian A. Gleissner, Norbert Leitinger, Klaus Ley (2007). Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis . Hypertension.

Christian A. Gleissner, Hyung Jun Cho, Pavel Shashkin, Dane Dunson, Nitin Jain, Jae K. Lee, Yury Miller, Klaus Ley (2007). Induction of dendritic cell-like phenotype in macrophages during foam cell formation . Physiological Genomics.

Christian A. Gleissner, Thomas J. Dengler, Roland Klingenberg, Falk-Udo Sack, Philipp A. Schnabel, Hugo A. Katus (2007). Biomarkers After Heart Transplantation: Nongenomic . Heart Failure Clinics.

Christian A. Gleissner, Arne Zastrow, Roland Klingenberg, Martin S. Kluger, Mathias Konstandin, Sultan Celik, Susanne Haemmerling, Vijay Shankar, Thomas Giese, Hugo A. Katus, et al. (2007). IL‐10 inhibits endothelium‐dependent T cell costimulation by up‐regulation of ILT3/4 in human vascular endothelial cells . European Journal of Immunology.

Christian Gleissner, Klaus Ley (2007). CXCL4 in atherosclerosis: Possible roles in monocyte arrest and macrophage foam cell formation . Thrombosis and Haemostasis.

C.A. Gleissner, A. Doesch, P. Ehlermann, A. Koch, F.U. Sack, H.A. Katus, T.J. Dengler (2006). Cyclosporine Withdrawal Improves Renal Function in Heart Transplant Patients on Reduced-Dose Cyclosporine Therapy . American Journal of Transplantation.

Christian A. Gleissner, Roland Klingenberg, Peter Staritz, Achim Koch, Philipp Ehlermann, Alfred Wiggenhauser, Thomas J. Dengler (2006). Role of erythropoietin in anemia after heart transplantation . International Journal of Cardiology.

Roland Klingenberg, Christian Gleissner, Achim Koch, Philipp A. Schnabel, Falk-Udo Sack, Rainer Zimmermann, Hugo A. Katus, Thomas J. Dengler (2005). Impact of Pre-Operative Diabetes Mellitus Upon Early and Late Survival After Heart Transplantation: A Possible Era Effect . The Journal of Heart and Lung Transplantation.

Roland Klingenberg, Frank Autschbach, Christian Gleissner, Thomas Giese, Nadine Wambsganss, Natascha Sommer, Guenther Richter, Hugo A. Katus, Thomas J. Dengler (2005). Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cellsin vitro . European Journal of Immunology.

Roland Klingenberg, Achim Koch, Christian Gleissner, Philipp A. Schnabel, Markus Haass, Andrew Remppis, Hugo A. Katus, Thomas J. Dengler (2005). Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation* . Transplant International.

Christian A. Gleissner, Ammanouil Murat, Susanne Sch??fer, Roland Klingenberg, Achim Koch, Andrew Remppis, Rainer Zimmermann, Hugo A. Katus, Thomas J. Dengler (2004). Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function1 . Transplantation.

Christian A Gleissner, Roland Klingenberg, Winfried Nottmeyer, Stephan Zipfel, Falk‐Udo Sack, Philipp A Schnabel, Markus Haass, Thomas J Dengler (2003). Diagnostic efficiency of rejection monitoring after heart transplantation with cardiac troponin T is improved in specific patient subgroups . Clinical Transplantation.

C.A Gleissner, J Zehelein, F.U Sack, P Schnabel, M Haass, T.J Dengler (2002). Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantation . Transplantation Proceedings.

Christian Albert Gleissner Entzündungen und kardiovaskuläres Risiko. CardioNews 2021.

BOOK CHAPTER

Christian A. Gleissner (2015). CXCL4 und CXCL4L1 . Encyclopedia of Inflammatory Diseases.

Christian Albert Gleissner (2012). CXCL4 (Platelet factor-4) inhibits foam cell formation in human macrophages. Aktuelle Beiträge zur Arterioskleroseforschung, Deutsche Gesellschaft für Arterioskleroseforschung e.V., Tübingen, ISBN 978-3-936423-09-9.

Christian Albert Gleissner (2011). CXCL4-induced macrophages: A novel therapeutic target in human atherosclerosis?. Atherogenesis, InTech – Open Access Publisher, Rijeka, Croatia. ISBN 978-953-307-992-9.